Explore the vast range of titles available.

Stem cells regulate their fate by binding to, and contracting against, the extracellular matrix. Recently, it has been proposed that in addition to matrix stiffness and ligand type, the degree of coupling of fibrous protein to the surface of the underlying substrate, that is, tethering and matrix porosity, also regulates stem cell differentiation. By modulating substrate porosity without altering stiffness in polyacrylamide gels, we show that varying substrate porosity did not significantly change protein tethering, substrate deformations, or the osteogenic and adipogenic differentiation of human adipose-derived stromal cells and marrow-derived mesenchymal stromal cells. Varying protein–substrate linker density up to 50-fold changed tethering, but did not affect osteogenesis, adipogenesis, surface–protein unfolding or underlying substrate deformations. Differentiation was also unaffected by the absence of protein tethering. Our findings imply that the stiffness of planar matrices regulates stem cell differentiation independently of protein tethering and porosity. Recent work has proposed that both protein tethering to the extracellular matrix and matrix porosity can regulate stem cell differentiation. It is now shown that differentiation is driven by matrix stiffness independently of tethering and porosity.

Synapses are specialized structures that mediate rapid and efficient signal transmission between neurons and are surrounded by glial cells. Astrocytes develop an intimate association with synapses in the central nervous system (CNS) and contribute to the regulation of ion and neurotransmitter concentrations. Together with neurons, they shape intercellular space to provide a stable milieu for neuronal activity. Extracellular matrix (ECM) components are synthesized by both neurons and astrocytes and play an important role in the formation, maintenance, and function of synapses in the CNS. The components of the ECM have been detected near glial processes, which abut onto the CNS synaptic unit, where they are part of the specialized macromolecular assemblies, termed perineuronal nets (PNNs). PNNs have originally been discovered by Golgi and represent a molecular scaffold deposited in the interface between the astrocyte and subsets of neurons in the vicinity of the synapse. Recent reports strongly suggest that PNNs are tightly involved in the regulation of synaptic plasticity. Moreover, several studies have implicated PNNs and the neural ECM in neuropsychiatric diseases. Here, we highlight current concepts relating to neural ECM and PNNs and describe an in vitro approach that allows for the investigation of ECM functions for synaptogenesis.

The ability of the environment to shape cortical function is at its highest during critical periods of postnatal development. In the visual cortex, critical period onset is triggered by the maturation of parvalbumin inhibitory interneurons, which gradually become surrounded by a specialized glycosaminoglycan-rich extracellular matrix: the perineuronal nets. Among the identified factors regulating cortical plasticity in the visual cortex, extracortical homeoprotein Otx2 is transferred specifically into parvalbumin interneurons and this transfer regulates both the onset and the closure of the critical period of plasticity for binocular vision. Here, we review the interaction between the complex sugars of the perineuronal nets and homeoprotein Otx2 and how this interaction regulates cortical plasticity during critical period and in adulthood.

The substrate of matrix metalloproteinase 11 (MMP11) remains unknown. We have recently shown that MMP11 is a negative regulator of adipogenesis, able to reduce and even to revert mature adipocyte differentiation. Here, we have used mouse 3T3L1 cells and human U87MG and SaOS cells to show that MMP11 cleaves the native α3 chain of collagen VI, which is an adipocyte-related extracellular matrix component. It is known that extracellular proteolytic processing of this chain is required for correct collagen VI folding. Interestingly, MMP11-deficient fat tissue is less cohesive and exhibits collagen VI alteration, dramatic adipocyte plasma and basement membrane abnormalities and lipid leakage. MMP11 is thus required for correct collagen VI folding and therefore for fat tissue cohesion and adipocyte function. Both MMP11 and collagen VI favor tumor progression. Similar spatio-temporal overexpression at the adipocyte–cancer cell interface has been reported for the two proteins. MMP11-dependent collagen VI processing might therefore be expected to occur during malignancy. Accordingly, collagen VI no longer delineates adipocytes located at the invasive front of breast carcinomas. In conclusion, the native α3 chain of collagen VI constitutes a specific MMP11 substrate. This MMP11 collagenolytic activity is functional in fat tissue ontogenesis as well as during cancer invasive steps.

•  Introduction •  ECM: composition and structure ‐  Collagen ‐  Laminin ‐  Fibronectin ‐  Elastin ‐  Nidogen ‐  Glycosaminoglycans ‐  Perlecan ‐  Syndecans ‐  Receptors for ECM molecules •  Evaluation of ECM molecules and their modulators in vessel formation ‐  Determination of essential ECM components of vessel formation ‐  Collagen‐I and laminins are important for vessel structural integrity and provide contrasting signals in angiogenesis ‐  The function of collagens in the blood vessel basement membrane ‐  Laminin α4 is a key molecule in basement membrane assembly, microvessel stability and maturation ‐  Fibronectin is essential for vascular development ‐  Perlecan and syndecans modulate growth factors in angiogenesis ‐  Fragments of ECM proteins regulate angiogenic processes ‐  Proteins involved in signalling through ECM molecules ‐  Thrombospondins ‐  CCN proteins •  ECM signalling in vessel formation: what next? The extracellular matrix plays a number of important roles, among them providing structural support and information to cellular structures such as blood vessels imbedded within it. As more complex organisms have evolved, the matrix ability to direct signalling towards the vasculature and remodel in response to signalling from the vasculature has assumed progressively greater importance. This review will focus on the molecules of the extracellular matrix, specifically relating to vessel formation and their ability to signal to the surrounding cells to initiate or terminate processes involved in blood vessel formation.

Key Points Malignant progression of benign tumours is typically associated with an angiogenic switch — the transition from a quiescent to a proliferative vasculature. The de novo recruitment of various innate immune cells was shown to trigger the angiogenic switch in mouse tumour models. Macrophages are important pro-angiogenic cells in the tumour microenvironment. They promote tumour angiogenesis mainly by secreting pro-angiogenic growth factors and facilitating the degradation of the perivascular extracellular matrix. Neutrophils and immature myeloid cells have important roles during the initial angiogenic switch in experimental tumour models. They were also found to sustain tumour revascularization in the context of anti-angiogenic therapy. B cells and T cells may either promote or limit tumour angiogenesis depending on the specific subtype and activation state. In the context of immunotherapy, they may induce the regression of tumour blood vessels. Tumour blood vessels typically display scant pericyte coverage. However, pericytes provide pro-survival cues to angiogenic blood vessels, and their pharmacological targeting improves tumour response to anti-angiogenic therapy. Cancer-associated fibroblasts produce the extracellular matrix and are an important source of pro-angiogenic factors and myeloid cell chemoattractants in the tumour microenvironment. Adipocytes stimulate peri-tumoural angiogenesis by secreting pro-inflammatory and pro-angiogenic cytokines, and by releasing fatty acids that are consumed by angiogenic endothelial cells. The extracellular matrix conveys both pro-angiogenic and angiostatic signals to tumour blood vessels. The metabolic properties of cancer cells and tumour-associated stromal cells influence angiogenesis in many ways (for example, by regulating glucose bioavailability to angiogenic blood vessels). Vascular heterogeneity is a hallmark of cancer and is determined by multiple factors, including the specific organ and tissue in which the tumour arises, the composition of tumour-associated stromal cells, as well as the nature, diversity and relative abundance of pro- and anti-angiogenic mediators. Tumour-associated stromal cells modulate tumour responses to anti-angiogenic therapy. This Review discusses the extrinsic regulation of angiogenesis by the tumour microenvironment, highlighting potential vulnerabilities that could be targeted to improve the applicability and reach of anti-angiogenic cancer therapies. Tumours display considerable variation in the patterning and properties of angiogenic blood vessels, as well as in their responses to anti-angiogenic therapy. Angiogenic programming of neoplastic tissue is a multidimensional process regulated by cancer cells in concert with a variety of tumour-associated stromal cells and their bioactive products, which encompass cytokines and growth factors, the extracellular matrix and secreted microvesicles. In this Review, we discuss the extrinsic regulation of angiogenesis by the tumour microenvironment, highlighting potential vulnerabilities that could be targeted to improve the applicability and reach of anti-angiogenic cancer therapies.

Perineuronal nets (PNNs) are aggregates of extracellular matrix molecules surrounding several types of neurons in the adult CNS, which contribute to stabilising neuronal connections. Interestingly, a reduction of PNN number and staining intensity has been observed in conditions associated with plasticity in the adult brain. However, it is not known whether spontaneous PNN changes are functional to plasticity and repair after injury. To address this issue, we investigated PNN expression in the vestibular nuclei of the adult mouse during vestibular compensation, namely the resolution of motor deficits resulting from a unilateral peripheral vestibular lesion. After unilateral labyrinthectomy, we found that PNN number and staining intensity were strongly attenuated in the lateral vestibular nucleus on both sides, in parallel with remodelling of excitatory and inhibitory afferents. Moreover, PNNs were completely restored when vestibular deficits of the mice were abated. Interestingly, in mice with genetically reduced PNNs, vestibular compensation was accelerated. Overall, these results strongly suggest that temporal tuning of PNN expression may be crucial for vestibular compensation.

Cell-cell communication, facilitating the exchange of small metabolites, ions and second messengers, takes place via aqueous proteinaceous channels called gap junctions. Connexins (cx) are the subunits of a gap junction channel. Mutations in zebrafish cx43 produces the short fin (sof (b123) ) phenotype and is characterized by short fins due to reduced segment length of the bony fin rays and reduced cell proliferation. Previously established results from our lab demonstrate that Cx43 plays a dual role regulating both cell proliferation (growth) and joint formation (patterning) during the process of skeletal morphogenesis. In this study, we show that Hapln1a (Hyaluronan and Proteoglycan Link Protein 1a) functions downstream of cx43. Hapln1a belongs to the family of link proteins that play an important role in stabilizing the ECM by linking the aggregates of hyaluronan and proteoglycans. We validated that hapln1a is expressed downstream of cx43 by in situ hybridization and quantitative RT-PCR methods. Moreover, in situ hybridization at different time points revealed that hapln1a expression peaks at 3 days post amputation. Expression of hapln1a is located in the medial mesenchyme and the in the lateral skeletal precursor cells. Furthermore, morpholino mediated knock-down of hapln1a resulted in reduced fin regenerate length, reduced bony segment length and reduced cell proliferation, recapitulating all the phenotypes of cx43 knock-down. Moreover, Hyaluronic Acid (HA) levels are dramatically reduced in hapln1a knock-down fins, attesting the importance of Hapln1a in stabilizing the ECM. Attempts to place hapln1a in our previously defined cx43-sema3d pathway suggest that hapln1a functions in a parallel genetic pathway. Collectively, our data suggest that Cx43 mediates independent Sema3d and Hapln1a pathways in order to coordinate skeletal growth and patterning.

We examine the relationships of three variables (projected area, migration speed, and traction force) at various type I collagen surface densities in a population of fibroblasts. We observe that cell area is initially an increasing function of ligand density, but that above a certain transition level, increases in surface collagen cause cell area to decline. The threshold collagen density that separates these two qualitatively different regimes, ∼160 molecules/ μm 2, is approximately equal to the cell surface density of integrin molecules. These results suggest a model in which collagen density induces a qualitative transition in the fundamental way that fibroblasts interact with the substrate. At low density, the availability of collagen binding sites is limiting and the cells simply try to flatten as much as possible by pulling on the few available sites as hard as they can. The force per bond under these conditions approaches 100 pN, approximately equal to the force required for rupture of integrin-peptide bonds. In contrast, at high collagen density adhesion, traction force and motility are limited by the availability of free integrins on the cell surface since so many of these receptors are bound to the surface ligand and the force per bond is very low.

Key Points Stem cells are regulated by cell-intrinsic and cell-extrinsic forces in development, homeostasis and regeneration. Mechanical tension regulates early embryogenesis ex vivo in embryoid self-organization, germ-band elongation, invagination and dorsal closure, and sorting of the germ layers. During development, mechanical forces regulate the generation of organ systems by directing the specification and expansion of stem cells, as well as re-organizing the extracellular matrix that begins to accumulate in embryonic tissues. Synthetic matrices enable the control of biophysical properties of the stem cell niche in order to test specific hypotheses on how mechanical cues regulate stem cells. Synthetic matrices have been used to demonstrate how mechanical cues, such as stiffness and viscoelasticity, as well as externally applied mechanical loads, control stem cell self-renewal and proliferation, differentiation and organoid formation. Externally applied mechanical forces can stimulate stem cells to promote tissue regeneration. Physical cues regulate stem cell fate and function during embryonic development and in adult tissues. The biophysical and biochemical properties of the stem cell microenvironment can be precisely manipulated using synthetic niches, which provide key insights into how mechanical stimuli regulate stem cell function and can be used to maintain and guide stem cells for regenerative therapies. Stem cells and their local microenvironment, or niche, communicate through mechanical cues to regulate cell fate and cell behaviour and to guide developmental processes. During embryonic development, mechanical forces are involved in patterning and organogenesis. The physical environment of pluripotent stem cells regulates their self-renewal and differentiation. Mechanical and physical cues are also important in adult tissues, where adult stem cells require physical interactions with the extracellular matrix to maintain their potency. In vitro , synthetic models of the stem cell niche can be used to precisely control and manipulate the biophysical and biochemical properties of the stem cell microenvironment and to examine how the mode and magnitude of mechanical cues, such as matrix stiffness or applied forces, direct stem cell differentiation and function. Fundamental insights into the mechanobiology of stem cells also inform the design of artificial niches to support stem cells for regenerative therapies.